Form 4: Arteris Director Wayne Cantwell Reports Acquisition of Restricted Stock Units
Insider Transaction Report
Arteris, Inc. Director Wayne C. Cantwell has reported the acquisition of 34,732 restricted stock units (RSUs) as part of his compensation, aligning his interests with shareholders.
Summary
- Wayne C. Cantwell, a Director of Arteris, Inc. (AIP), reported a transaction on June 3, 2025, involving the acquisition of company securities.
- The transaction involved the acquisition of 34,732 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0.00.
- Each RSU represents a contingent right to receive one share of Arteris' common stock.
- These RSUs are set to vest in full on the earlier of (i) the first anniversary of the grant date or (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, contingent on Mr. Cantwell's continued service to the Board.
- Mr. Cantwell elected to defer the receipt of these shares.
- Following this transaction, Mr. Cantwell directly beneficially owns 262,930 shares of Common Stock and indirectly owns 38,761 shares through the Decathlon Capital Management 401K Plan FBO Wayne Cantwell.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the RSU grant aligns the director's interests with shareholders, which is generally viewed favorably for corporate governance and long-term value creation.
Positives
- The acquisition of Restricted Stock Units by a director aligns their financial interests with those of the company's shareholders, incentivizing long-term performance.
- The grant of RSUs at a $0.00 price is a common form of equity compensation for directors, reflecting confidence in the company's future value.
Risks
- The vesting of the RSUs is contingent upon the reporting person continuing to provide services to the Issuer's Board through the vesting date, meaning the shares are not guaranteed if service ceases.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.
Industry Context
The grant of Restricted Stock Units to a director is a standard practice in corporate governance across various industries, including the technology sector where Arteris operates, to attract and retain qualified board members and align their interests with long-term company success.
Comparison to Industry Standards
- The structure of RSU grants with service-based vesting is a common compensation mechanism for directors in publicly traded companies, comparable to practices at technology firms like Synopsys, Cadence Design Systems, or Rambus, which also utilize equity incentives to align director and executive interests with shareholder value creation.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's interests with shareholders, potentially leading to better long-term decision-making focused on increasing shareholder value.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- The Restricted Stock Units will vest on the earlier of the first anniversary of the grant date or immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of transaction for the acquisition of Restricted Stock Units. |
| 06/05/2025 | Date the Form 4 was signed. |
Keywords
Arteris Inc., AIP, Form 4, SEC filing, insider transaction, restricted stock units, RSUs, beneficial ownership, director compensation, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.